Laboratory-based surveillance of paratyphoid fever in the United States: Travel and antimicrobial resistance

Clinical Infectious Diseases

Volumn 46, Issue 11, 2008, Pages 1656-1663

  Gupta, Sundeep K ^a,b   Medalla, Felicita ^a   Omondi, Michael W ^a   Whichard, Jean M ^a   Fields, Patricia I ^a   Gerner Smidt, Peter ^a   Patel, Nehal J ^a   Cooper, Kara L F ^a   Chiller, Tom M ^a   Mintz, Eric D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AFRICA; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA PARATYPHI; SALMONELLA PARATYPHI B; SALMONELLA PARATYPHI C; SALMONELLOSIS; SEROTYPE; SOUTH ASIA; UNITED STATES; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; PARATYPHOID FEVER; SALMONELLA INFECTIONS; SALMONELLA PARATYPHI A; SALMONELLA PARATYPHI B; SALMONELLA PARATYPHI C; SALMONELLA TYPHI; TRAVEL; UNITED STATES;

EID: 43949107944     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/587894     Document Type: Article

References (40)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull WHO 2004; 82:346-53.
2. Threlfall EJ, Fisher IS, Berghold C, et al. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001. Int J Antimicrob Agents 2003; 22:487-91.
3. BaiQing D, Jin Y, MingLiu W, Wang ML. Analysis of prevalent status of paratyphoid A and typhoid in Guangxi Autonomous Region in 1994-2002. China Trop Med 2004; 4:177-9.
4. Tankhiwale SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype paratyphi A in patients with enteric fever. Indian J Med Res 2003; 117:10-2.
5. Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42:1247-53.
6. Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11:1038-43.
7. Thisyakorn U, Mansuwan P, Taylor DN. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am J Dis Child 1987; 141:862-5.
8. Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travelers: a nationwide study. J Travel Med 2005; 12:275-81.
9. Karim M, Islam N. Salmonella meningitis: report of three cases in adults and literature review. Infection 2002; 30:104-8.
10. Vaisbein E, Melamed-Snapiri Y, Nassar F. Salmonella paratyphi endocarditis. Acta Cardiol 2006; 61:191-2.
11. Rajagopal A, Ramasamy R, Mahendran G, Thomas M. Hepatic abscess complicating paratyphoid infection. Trop Gastroenterol 2002; 23:181-2.
12. Navin P, Thambu DS, Venugopal R, Subhash HS, Thomas K. Salmonella paratyphi osteomyelitis and psoas abscess. Trop Doct 2006; 36:58-9.
13. Caygill CP, Hill MJ, Braddick M, Sharp JC. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 1994; 343:83-4.
14. Khattak BK, Raja KM. Salmonella paratyphi A induced pancytopenia: a new association. J Pak Med Assoc 1995; 45:192-3.
15. Vugia DJ, Samuel M, Farley MM, et al. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004; 38(Suppl 3):S149-56.
16. Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 1991; 85:113-6.
17. Woodward TE, Smadel JE, Ley HL, Green R, Manikar DS. Preliminary report of the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann Intern Med 1948; 29:131-4.
18. Slinger R, Desjardins M, McCarthy AE, et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004; 4:36.
19. Safdar A, Kaur H, Elting L, Rolston KV. Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from northern India. Chemotherapy 2004; 50:88-91.
20. Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100:1063-7.
21. Prager R, Rabsch W, Streckel W, Voigt W, Tietze E, Tschape H. Molecular properties of Salmonella enterica serotype paratyphi B distinguish between its systemic and its enteric pathovars. J Clin Microbiol 2003; 41:4270-8.
22. Centers for Disease Control and Prevention. Salmonella surveillance: annual summary, 2005. Atlanta: Centers for Disease Control and Prevention, 2007.
23. Ewing WH, ed. Edwards and Ewing's identification of Enterobacteriaceae. 4th ed. New York: Elsevier, 1986.
24. Malorny B, Bunge C, Helmuth R. Discrimination of d-tartrate-fermenting and -nonfermenting Salmonella enterica subsp. enterica isolates by genotypic and phenotypic methods. J Clin Microbiol 2003; 41:4292-7.
25. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157: H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006; 3:59-67.
26. Centers for Disease Control and Prevention. Foodborne Diseases Active Surveillance Network (FoodNet): population survey atlas of exposures, 2002. Atlanta: Centers for Disease Control and Prevention, 2004.
27. Kariuki S, Cheesbrough J, Mavridis AK, Hart CA. Typing of Salmonella enterica serotype paratyphi C isolates from various countries by plasmid profiles and pulsed-field gel electrophoresis. J Clin Microbiol 1999; 37:2058-60.
28. Harish BN, Madhulika U, Parija SC. Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A. J Med Microbiol 2004; 53:819.
29. Pandit A, Arjyal A, Day JN, et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2007; 2:e542.
30. Thaver D, Zaidi AK, Critchley J, Madni SA, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2005:CD004530.
31. Chandel DS, Nisar N, Thong KL, Pang T, Chaudhry R. Role of molecular typing in an outbreak of Salmonella paratyphi A. Trop Gastroenterol 2000; 21:121-3.
32. Meltzer E, Yossepowitch O, Sadik C, Dan M, Schwartz E. Epidemiology and clinical aspects of enteric fever in Israel. Am J Trop Med Hyg 2006; 74:540-5.
33. Ochiai RL, Wang X, von Seidlein L, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 2005; 11:1764-6.
34. Typhoid fever and paratyphoid fever in Japan, 2001-2004: infectious agents surveillance report. Tokyo, Japan: National Institute of Infectious Diseases, 2005; 26.
35. Ekdahl K, de Jong B, Andersson Y. Risk of travel-associated typhoid and paratyphoid fevers in various regions. J Travel Med 2005; 12:197-204.
36. Malla S, Kansakar P, Serichantalergs O, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44:18-22.
37. Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004; 291:2856-64.
38. Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis 2007; 45(Suppl 1):S24-8.
39. Han KH, Choi SY, Lee JH, et al. Isolation of Salmonella enterica subspecies enterica serovar Paratyphi B dT+, or Salmonella Java, from Indonesia and alteration of the d-tartrate fermentation phenotype by disrupting the ORF STM 3356. J Med Microbiol 2006; 55:1661-5.
40. U.S. resident travel abroad historical visitation - outbound 1995-2005. Available at: http://tinet.ita.doc.gov/view/f-2005-11-001/index.html. Accessed 28 July 2007.